Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126631592 | 12663159 | 2 | F | 20160724 | 20160817 | 20160818 | 20160819 | EXP | PHHY2016BR113030 | NOVARTIS | 84.48 | YR | F | Y | 64.00000 | KG | 20160819 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126631592 | 12663159 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 18 MG/10 CM2 PATCH, 9.5 MG | 22083 | 9.5 | MG | TRANS-THERAPEUTIC-SYSTEM | |||||||
| 126631592 | 12663159 | 2 | C | MEMANTINA | MEMANTINE HYDROCHLORIDE | 1 | Oral | 2 DF, QD | 0 | 2 | DF | TABLET | QD | ||||||
| 126631592 | 12663159 | 3 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126631592 | 12663159 | 1 | Dementia Alzheimer's type |
| 126631592 | 12663159 | 2 | Dementia Alzheimer's type |
| 126631592 | 12663159 | 3 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126631592 | 12663159 | DE |
| 126631592 | 12663159 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126631592 | 12663159 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |